Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 3/20 | 0.38 |
| ▸ | PKLR | P30613 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5999503 | 0.93 | KCNH2 (0.34) | FFAR1HTR2ASLC6A4KCNH2NPC1 | |
| Formic Acid SCHEMBL6000270 | 0.83 | FFAR1 (0.39) | FFAR1PKLRHTR2ASLC6A4KCNH2 | |
| Formic Acid SCHEMBL6000262 | 0.82 | SLC6A4 (0.45) | FFAR1PKLRHTR2ASLC6A4KCNH2 | |
| SCHEMBL6000452 | 0.81 | HTR2A (0.41) | HTR2ASLC6A4RAB9A | |
| SCHEMBL5999794 | 0.77 | HTR2A (0.33) | HTR2ASLC6A4KCNH2CA12CA2 | |
| Formic Acid SCHEMBL5999505 | 0.76 | CHRM2 (0.36) | FFAR1HTR2ASLC6A4KCNH2PPARG | |
| SCHEMBL5999804 | 0.74 | HTR2A (0.39) | FFAR1PKLRHTR2ASLC6A4KCNH2 | |
| Formic Acid SCHEMBL5999499 | 0.74 | SLC6A4 (0.45) | HTR2ASLC6A4KCNH2 | |
| SCHEMBL6000432 | 0.71 | HTR2A (0.32) | HTR2ASLC6A4KCNH2 | |
| SCHEMBL6000410 | 0.70 | HTR2A (0.39) | HTR2ASLC6A4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060058361-A1 | Therapeutic diphenyl ether ligands | PFIZER INC | 2006-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058361-A1 | Therapeutic diphenyl ether ligands | HTR2B, HTR2C, HTR3B | FFAR1 269/4885PKLR 1795/4885HTR2A 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.